EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Semaphorin 3G Is Associated With CASP12/BIRC5 Expression and Apoptosis in Breast Cancer, Contributing to Improved Prognosis for Breast Cancer Patients

Yuan Shi, Yongjie Hou, Jingwei Shen, Jiacai Liu, Haijun Yang, Wei Niu, Weiyun Wang, Zhiying Cui, Xianhua Qiu, Jianyun Guan, Jing Wang, Xiaotong Zhang, Weijie Wang

International Journal of Clinical Practice · 2026-01 · 2026 (1)

DOI: 10.1155/ijcp/8469744 ↗
AbstractBibliografische Angaben

Abstract

The semaphorin (SEMA) gene family plays a crucial role in tumor development, yet there are no existing studies on its integrity in breast cancer. The aim of the present study was to examine the role of the SEMA gene family in breast cancer and elucidate its potential functions. The present study included the use of weighted gene co‐expression network analysis to identify genes potentially associated with SEMA. In addition, a robust SEMA prognostic model was constructed utilizing the least absolute shrinkage and selection operator approach. Flow cytometry, Transwell assay, and scratch experiments were used to prove the functional impact of SEMA3G on breast cancer. Upon scrutinizing the differentially expressed genes, a marked upregulation of SEMA3A, SEMA3E, SEMA3G, and SEMA5A was confirmed in noncancerous breast tissue. In addition, the expression of SEMA genes exhibited associations with the pathological T stage. Prognostic analysis further unveiled the prognostic potential of SEMA3C, SEMA3F, SEMA3G, and SEMA3B in breast cancer. Furthermore, through a meticulous immune‐related analysis, the SEMA prognostic model was associated with differences in dendritic cell and T cell infiltration. The present study found that SEMA3G overexpression increased tumor apoptosis and reduced cell migration; moreover, SEMA3G expression was correlated with the apoptosis‐related genes caspase 12 (CASP12) and baculoviral IAP repeat containing 5 (BIRC5). Through multiomics analysis, the SEMA gene family was identified as a significant factor in breast cancer. Concurrently, functional experiments on SEMA3G highlighted its critical role, offering a novel perspective for future exploration of the underlying mechanisms of breast cancer.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →